The FDA acknowledges that all research and audit methodologies have underlying assumptions. The FDA is transparent about its assumptions as illustrated through its Talking Points (Public Communication) Series, and it is open to amending its assumptions subject to more sound reasons and objective measurements. Also, the FDA acknowledges that its measurements, findings, and assumptions may not be agreeable to all stakeholders. The FDA accepts this reality, while at the same time strives for the utmost research and audit rigor. The FDA does not claim to be the sole authority on democratic processes; rather, the FDA is a source of educational knowledge and research on the impact of democratic processes on the welfare of individuals.
Through the ongoing Talking Points Series as mentioned, the FDA is transparent about its assumptions and seeks public dialogue on these assumptions in order to improve its research and audits and further its mission of people more knowledgeable about the impact of democratic processes and can then make more informed decisions.
2013 FDA Talking Points Series: